Semaglutide, the weight management drug sold as Ozempic and Wegovy, may reduce the risk of Alzheimer's disease by 40% to 70% ...

People with type 2 diabetes who use semaglutide drugs like Ozempic and Wegovy appear to have a lower risk of Alzheimer's ...

For years, scientists have observed a connection between type 2 diabetes and an increased risk of dementia, particularly ...

It’s the active ingredient in Novo Nordisk’s Ozempic and Wegovy; Study done in comparison of seven popular diabetes medicines ...

Compared to other anti-diabetic drugs, semaglutide, also known as Ozempic, may lower the risk of Alzheimer’s disease in ...

Semaglutide, the active ingredient in Ozempic and Wegovy, appeared to reduce the risk of Alzheimer’s disease in people with ...

Researchers use real-world data in the United States to evaluate the protective role of semaglutide against Alzherimer’s ...

A new study reveals that the active ingredient in drugs like Ozempic and Wegovy could lower the risk of developing ...

Researchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-loss ...

Could the drug that's changing the weight loss industry also protect older adults against the most common form of dementia?

Researchers at the Case Western Reserve School of Medicine have found that when compared to seven other anti-diabetic drugs, ...